Drugs / Buckberg Cardi-Braun
Buckberg Cardi-Braun
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06530641 Comparator | Dec 2024 → Nov 2026 expected | cardiac arrest | Lourdes Montero Cruces | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Buckberg Cardi-Braun | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06530641 ↗ |
| Known as | Buckberg Cardi-Braun cardioplegia solution. ATC: B05X A16. | “Buckberg Cardi-Braun cardioplegia solution. ATC: B05X A16.” NCT06530641 ↗ |